Tetra Therapeutics
Mr. Harvey Elgersma has more than 30 years of diversified experience in financial leadership. His CFO experience includes multiple mergers and acquisitions, strategies for increasing value, and developing both successful exit and growth strategies. Mr. Elgersma has worked with Perrigo; CHS, Inc.; Hamilton Farm Bureau Cooperative, Inc. and Cumberland Swan Holding Inc.
Mr. Elgersma holds a BBA in accounting from Grand Valley State University.
This person is not in any offices
Tetra Therapeutics
Tetra Therapeutics is a clinical-stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression, and schizophrenia.